fda position on bpc-157 peptide 10 questions to ask your doctor about peptides FDA panel votes to loosen

These fat-reducing effects occurred without changes in lean body mass, bone mineral density, or longitudinal bone growth, confirming that the peptide lacked the growth-promoting properties of intact growth hormone

NGF, NT-3, NT-4

Fatigue, depression, low motivation

An international study combining single-cell genomics, spatial transcriptomics and artificial intelligence has identified large-scale changes in three-dimensional genome organisation in Alzheimers-affected brain cells, establishing chromatin architecture as a previously overlooked component of the diseases molecular pathology and a potential framework for future therapeutic targeting

Thus, it offers a possible treatment avenue for this difficult condition